Acromegaly is a progressive rare disease associated with excessive growth hormone production. Described by progressive somatic disfigurement (mainly including the face and extremities) and causing multi-systemic arrangements. People with this disease are at risk of severe disability and life-threatening health problems. Acromegaly is a treacherous chronic disease that occurs with increased morbidity and mortality from cardiovascular, metabolic and neoplastic complications. Disease control can easily be assessed with modern clinical and laboratory methods, but the patient’s self-assessment of Wellbeing and Quality of Life is paramount. Although acromegaly is a rare disease, the burden on Health-related Quality of Life (HRQoL) is significant due to the wide range of concomitant complication and the need for lifelong management. The purpose of this review is to present actual data on the epidemiology of acromegaly and the impact of the disease on the Quality of Life of patients. For more information click here.
Rare Diseases and Orphan Drugs